WHARTON ISRAEL

CONFERENCE

Wharton Israel Conference Israel Flag
  • More

    Use tab to navigate through the menu items.

    HEALTH CARE INNOVATION

    OCTOBER 16, 2015

    PRESENTERS

    Dr. Rivka Riven Kreitman

    Teva 

    Dr. Einat Zisman

    FutuRx 

    Dr. Harvey Rubin

    Perelman School of Medicine

    Dr. Joanne Waldstreicher

    Johnson & Johnson 

     

    Ram Waisbourd

    Teva 

    Dr. Abraham Ludomirski

    SCP Vitalife 

    What does Johnson & Johnson's Chief Medical Officer think of Israel innovation?

    How does Teva save you money?

    What are health care investments paying off?

    Professor Guy David

     

    Professor Ezekiel Emanuel

     

    Shani Scharfstein Wangenheim WG'16

    Dr. Adda Grimberg

    TEAM

     

    Teva

    ElMindA

    ReWalk

    OurCrowd

    OurCrowd

    OurCrowd

    HIL Applied Medical

    PulmOne

    OurCrowd

    OurCrowd

    Sight Diagnostics

    Surgical Theater

    OurCrowd

    OurCrowd

    Syqe Medical

    HEADLINES

     

    Times of Israel: Brain-Tech Start-Up ElMindA Makes Worldwide "Most Innovative" List

     

    Swiss Biotech: ElMindA Named to World Economic Forum's Top 49 Tech Pioneers

     

    AP: Teva Buying Allergan for $40 Billion

     

    Zacks.com: Teva Announces Positive Results on Tardive Dyskinesia Drug

     

    Betaboston.com: Microchips Biotech and Teva Partner on Implants for Drug Delivery

    PROFILES

     

    Companies and people leveraging innovation from Israel to improve the world

     

     

    Special Thanks To Our

    INVESTORS

    Zehavit Cohen

    Howard & Elayne Levkowitz

    Fred & Tami Mack

    The Mitzner Family

    Michael Steinhardt

    ​

    ​

    STATE OF ISRAEL

    MINISTRY OF ECONOMY

    Wharton Israel Conference Jewish Funders Network